John J. Cush
Founder and Executive Editor at RheumNow
Know-it-Now. Info on RA, Stills disease, Lupus, Gout, Pregnancy, Spondylitis, Psoriasis, Drug Safety, Rheumatology Research, Medical Education & Drug Evaluation
Articles
-
Feb 29, 2024 |
healio.com | John J. Cush |Michael E Weinblatt |Arthur Kavanaugh
IntroductionThe discovery and introduction of corticosteroid therapy by Philip Hench in the late 1940s and early 1950s was a seminal advance in the treatment of inflammatory diseases, including rheumatoid arthritis (RA). Prior to the introduction of steroids, RA therapy was dominated by poorly effective and toxic therapies (aspirin and gold salts). The glucocorticoid compounds became well known for their impressive and rapid clinical efficacy in a variety of inflammatory clinical disorders.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 22K
- Tweets
- 28K
- DMs Open
- Yes
RT @Janetbirdope: #polyrefractory #RA = failed all classes in #rheumatoid #arthritis +inflammatory #arthritis Longer disease duration Late…
RheumNow’s expanded coverage of the #EULAR2025 Annual meeting is sponsored in part by Johnson & Johnson and UCB. All content chosen by RheumNow & its Faculty
Transcranial Stimulation is Effective in Fibromyalgia A randomized, controlled clinical trial in fibromyalgia (FM) has shown the efficacy of transcranial direct current stimulation (A-tDCS) (along with exercise and pain neuroscience education [PNE]), in alleviating the pain. https://t.co/P8SKs3JNEx